Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Yuanfeng, Xin"'
Autor:
Xin Gong, Yuheng Jiao, Hao Hu, Rongzhen Zhang, Wenwen Jia, Jun Zhao, Zhongmin Liu, Yuanfeng Xin, Wei Han
Publikováno v:
Contemporary Clinical Trials Communications, Vol 41, Iss , Pp 101350- (2024)
Background and objective: The use of mesenchymal stem cells for heart failure treatment has gained increasing interest. However, most studies have relied on a single injection approach, with no research yet confirming the effects of multiple administ
Externí odkaz:
https://doaj.org/article/e7a2ced501f54acf9deb0bb8350e5003
Autor:
Bowen Lin, Ying Shen, Pengfei Zhang, Yunli Shen, Yuying Gu, Xiaoyan He, Jimin Li, Ke Yang, Weifeng Shen, Qi Zhang, Yuanfeng Xin, Yehong Liu
Publikováno v:
ESC Heart Failure, Vol 10, Iss 4, Pp 2541-2549 (2023)
Abstract Aims We sought to investigate the relationship between circulating tissue plasminogen activator (t‐PA) level and long‐term outcomes in stable coronary artery disease patients with or without aortic valve sclerosis (AVSc). Methods and res
Externí odkaz:
https://doaj.org/article/15d52d6a44964f24acab24770fd46f2f
Autor:
Jing Liu, Xiaoting Liang, Mimi Li, Fang Lin, Xiaoxue Ma, Yuanfeng Xin, Qingshu Meng, Rulin Zhuang, Qingliu Zhang, Wei Han, Ling Gao, Zhiying He, Xiaohui Zhou, Zhongmin Liu
Publikováno v:
Stem Cell Research & Therapy, Vol 13, Iss 1, Pp 1-19 (2022)
Abstract Background Human umbilical cord-derived mesenchymal stem cells (HucMSCs) have been recognized as a promising cell for treating myocardial infarction (MI). Inflammatory response post MI is critical in determining the cardiac function and subs
Externí odkaz:
https://doaj.org/article/3e7bd95037fa44539840326b4c59b321
Autor:
Xiaoting Liang, Jing Liu, Mimi Li, Fang Lin, Rulin Zhuang, Qingshu Meng, Xiaoxue Ma, Yuanfeng Xin, Xin Gong, Zhiying He, Wei Han, Xiaohui Zhou, Zhongmin Liu
Publikováno v:
Stem Cells International, Vol 2023 (2023)
Overactive inflammatory responses contribute to progressive cardiac dysfunction after myocardial infarction (MI). Mesenchymal stem cell (MSC) has generated significant interest as potent immune modulators that can regulate excessive immune responses.
Externí odkaz:
https://doaj.org/article/58f0e61ce55546a69e03248cfe285563
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-6 (2021)
Abstract Background Aberrant right subclavian artery (ARSA) with associated Kommerell diverticulum (KD) is a rare congenital aortic disease. KD patients have a high risk of rupture, dissection, and compression of adjacent structures. Although several
Externí odkaz:
https://doaj.org/article/a7e7d35a1d3b4cc1abaed074e9da1964
Publikováno v:
Chemistry & Biodiversity. 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::980be850134b905e87196014cd3315f6
https://doi.org/10.1002/cbdv.202200730
https://doi.org/10.1002/cbdv.202200730
Autor:
Yuanfeng Xin, Zhongmin Liu, Yifei Hua, Chao Zhang, Wenjie Tang, Mian Wang, Hao Cao, Wanlu Li, Thomas J. Webster
Publikováno v:
Biomaterials Science. 9:1088-1103
Studies of nanomedicine have achieved dramatic progress in recent decades. However, the main challenges that traditional nanomedicine has to overcome include low accumulation at target sites and rapid clearance from the blood circulation. An interest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51e3fed1219f0426a12fbd76d5358657
https://doi.org/10.1039/d0bm01164a
https://doi.org/10.1039/d0bm01164a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jing Liu, Xiaoting Liang, Mimi Li, Fang Lin, Xiaoxue Ma, Yuanfeng Xin, Qingshu Meng, Rulin Zhuang, Qingliu Zhang, Wei Han, Zhiying He, Xiaohui Zhou, Zhongmin Liu
Background: Human umbilical cord-derived mesenchymal stem cells (HucMSCs) have been recognized as a promising cell for treating myocardial infarction (MI). Inflammatory response post MI is critical in determining the cardiac function and subsequent a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da61db4e260b39463bf047917f3cb361
https://doi.org/10.21203/rs.3.rs-1133603/v1
https://doi.org/10.21203/rs.3.rs-1133603/v1
Autor:
Jing, Liu, Xiaoting, Liang, Mimi, Li, Fang, Lin, Xiaoxue, Ma, Yuanfeng, Xin, Qingshu, Meng, Rulin, Zhuang, Qingliu, Zhang, Wei, Han, Ling, Gao, Zhiying, He, Xiaohui, Zhou, Zhongmin, Liu
Publikováno v:
Stem cell researchtherapy. 13(1)
Human umbilical cord-derived mesenchymal stem cells (HucMSCs) have been recognized as a promising cell for treating myocardial infarction (MI). Inflammatory response post MI is critical in determining the cardiac function and subsequent adverse left
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0c4f8335f3128b63ffc49424a1245ba5
https://pubmed.ncbi.nlm.nih.gov/35690805
https://pubmed.ncbi.nlm.nih.gov/35690805